ARTICLE | Company News
Genmab, Scancell cancer antibody deal
October 9, 2001 7:00 AM UTC
Genmab (CSE:GEN; NMarkt:GE9D) and Scancell (Nottingham, U.K.) partnered to develop human antibodies to cancer targets identified by Scancell using its cancer target discovery program. The companies wi...